Network modeling links breast cancer susceptibility and centrosome dysfunction

Nature Genetics

Volumn 39, Issue 11, 2007, Pages 1338-1349

  Pujana, Miguel Angel ^a,f   Han, Jing Dong J ^a,n   Starita, Lea M ^b,o   Stevens, Kristen N ^c   Tewari, Muneesh ^a,p   Ahn, Jin Sook ^a   Rennert, Gad ^d   Moreno, Víctor ^e,f   Kirchhoff, Tomas ^g   Gold, Bert ^h   Assmann, Volker ⁱ   Elshamy, Wael M ^a   Rual, Jean François ^a   Levine, Douglas ^g   Rozek, Laura S ^e   Gelman, Rebecca S ^j   Gunsalus, Kristin C ^k   Greenberg, Roger A ^a   Sobhian, Bijan ^a   Bertin, Nicolas ^a   Venkatesan, Kavitha ^a   Ayivi Guedehoussou, Nono ^a,j   Solé, Xavier ^f   Hernández, Pilar ^l   Lázaro, Conxi ^l   Nathanson, Katherine L ^m   Weber, Barbara L ^m   Cusick, Michael E ^a   Hill, David E ^a   Offit, Kenneth ^g   Livingston, David M ^a   Gruber, Stephen B ^c,e   Parvin, Jeffrey D ^b,q   Vidal, Marc ^a   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d CLALIT HEALTH SERVICES   (Israel)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^k NEW YORK UNIVERSITY   (United States)

^l BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^o UNIVERSITY OF WASHINGTON   (United States)

^p Fred Hutchinson Cancer Research Center   (United States)

^q THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CELL DAMAGE; CENTROSOME; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE LOCUS; GENOMICS; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEOMICS;

ANTIGENS, CD44; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CENTROSOME; COMPUTATIONAL BIOLOGY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURAL NETWORKS (COMPUTER); OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION MAPPING; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN;

EID: 35349024501     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2007.2     Document Type: Article

References (50)

1. Futreal, P.A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177-183 (2004).
2. Kitano, H. Cancer as a robust system: implications for anticancer therapy. Nat. Rev. Cancer 4, 227-235 (2004).
3. Khalil, I.G. & Hill, C. Systems biology for cancer. Curr. Opin. Oncol. 17, 44-48 (2005).
4. Thomas, R.K. et al. High-throughput oncogene mutation profiling in human cancer. Nat. Genet. 39, 347-351 (2007).
5. Sjoblom, T. et al. The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274 (2006).
6. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
7. Vidal, M. A biological atlas of functional maps. Cell 104, 333-339 (2001).
8. Matthews, L.R. et al. Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or 'interologs'. Genome Res. 11, 2120-2126 (2001).
9. Futreal, P.A. et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120-122 (1994).
10. Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71 (1994).
11. Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792 (1995).
12. Renwick, A. et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet. 38, 873-875 (2006).
13. Meijers-Heijboer, H. et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31, 55-59 (2002).
14. Su, A.I. et al. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA 99, 4465-4470 (2002).
15. Cunliffe, H.E. et al. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Res. 63, 7158-7166 (2003).
16. van't Veer, L.J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
17. Gunsalus, K.C. et al. Predictive models of molecular machines involved in Caenorhabditis elegans early embryogenesis. Nature 436, 861-865 (2005).
18. Maxwell, C.A. et al. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol. Biol. Cell 14, 2262-2276 (2003).
19. Entwistle, J., Hall, C.L. & Turley, E.A. HA receptors: regulators of signalling to the cytoskeleton. J. Cell. Biochem. 61, 569-577 (1996).
20. Boulton, S.J. et al. BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans. Curr. Biol. 14, 33-39 (2004).
21. Li, S. et al. A map of the interactome network of the metazoan C. elegans. Science 303, 540-543 (2004).
22. Bellanger, J.M. & Gonczy, P. TAC-1 and ZYG-9 form a complex that promotes microtubule assembly in C. elegans embryos. Curr. Biol. 13, 1488-1498 (2003).
23. Le Bot, N., Tsai, M.C., Andrews, R.K. & Ahringer, J. TAC-1, a regulator of microtubule length in the C. elegans embryo. Curr. Biol. 13, 1499-1505 (2003).
24. Srayko, M., Quintin, S., Schwager, A. & Hyman, A.A. Caenorhabditis elegans TAC-1 and ZYG-9 form a complex that is essential for long astral and spindle microtubules. Curr. Biol. 13, 1506-1511 (2003).
25. Maxwell, C.A., Keats, J.J., Belch, A.R., Pilarski, L.M. & Reiman, T. Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Res. 65, 850-860 (2005).
26. Hsu, L.C. & White, R.L. BRCA1 is associated with the centrosome during mitosis. Proc. Natl. Acad. Sci. USA 95, 12983-12988 (1998).
27. Marmorstein, L.Y. et al. A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression. Cell 104, 247-257 (2001).
28. Bieche, I., Tozlu, S., Girault, I. & Lidereau, R. Identification of a three-gene expression signature of poor-prognosis breast carcinoma. Mol. Cancer 3, 37 (2004).
29. Freed, E. et al. Components of an SCF ubiquitin ligase localize to the centrosome and regulate the centrosome duplication cycle. Genes Dev. 13, 2242-2257 (1999).
30. Hashizume, R. et al. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276, 14537-14540 (2001).
31. Starita, L.M. et al. BRCA1-dependent ubiquitination of γ-tubulin regulates centrosome number. Mol. Cell. Biol. 24, 8457-8466 (2004).
32. Ouchi, M. et al. BRCA1 phosphorylation by aurora-A in the regulation of G2 to M transition. J. Biol. Chem. 279, 19643-19648 (2004).
33. Wang, X. et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25, 7148-7158 (2006).
34. Claus, E.B., Risch, N.J. & Thompson, W.D. Using age of onset to distinguish between subforms of breast cancer. Ann. Hum. Genet. 54, 169-177 (1990).
35. Mitchell, M.K., Gregersen, P.K., Johnson, S., Parsons, R. & Vlahov, D. The New York Cancer Project: rationale, organization, design, and baseline characteristics. J. Urban Health 81, 301-310 (2004).
36. Raff, J.W. Centrosomes and cancer: lessons from a TACC. Trends Cell Biol. 12, 222-225 (2002).
37. Joukov, V. et al. The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly. Cell 127, 539-552 (2006).
38. Lingle, W.L. et al. Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. USA 99, 1978-1983 (2002).
39. Pihan, G.A., Wallace, J., Zhou, Y. & Doxsey, S.J. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 63, 1398-1404 (2003).
40. Tutt, A. et al. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol. 9, 1107-1110 (1999).
41. Xu, X. et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389-395 (1999).
42. Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9-23 (2007).
43. Han, J.D. et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430, 88-93 (2004).
44. Kim, S.K. et al. A gene expression map for Caenorhabditis elegans. Science 293, 2087-2092 (2001).
45. Formstecher, E. et al. Protein interaction mapping: a Drosophila case study. Genome Res. 15, 376-384 (2005).
46. Giot, L. et al. A protein interaction map of Drosophila melanogaster. Science 302, 1727-1736 (2003).
47. Peri, S. et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res. 32, D497-D501 (2004).
48. Walhout, A.J. & Vidal, M. High-throughput yeast two-hybrid assays for large-scale protein interaction mapping. Methods 24, 297-306 (2001).
49. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265 (2005).
50. Solé, X., Guinó, E., Valls, J., Iniesta, R. & Moreno, V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 22, 1928-1929 (2006).